Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jan 1;29(1):1-10.
doi: 10.4062/biomolther.2020.178.

COVID-19 Vaccine: Critical Questions with Complicated Answers

Mohammad Faisal Haidere  1 , Zubair Ahmed Ratan  2   3 , Senjuti Nowroz  4 , Sojib Bin Zaman  5 , You-Jung Jung  6 , Hassan Hosseinzadeh  2 , Jae Youl Cho  7
Affiliations
Review

COVID-19 Vaccine: Critical Questions with Complicated Answers

Mohammad Faisal Haidere et al. Biomol Ther (Seoul). .

Abstract

COVID-19 has caused extensive human casualties with significant economic impacts around the globe, and has imposed new challenges on health systems worldwide. Over the past decade, SARS, Ebola, and Zika also led to significant concerns among the scientific community. Interestingly, the SARS and Zika epidemics ended before vaccine development; however, the scholarly community and the pharmaceutical companies responded very quickly at that time. Similarly, when the genetic sequence of SARSCoV-2 was revealed, global vaccine companies and scientists have stepped forward to develop a vaccine, triggering a race toward vaccine development that the whole world is relying on. Similarly, an effective and safe vaccine could play a pivotal role in eradicating COVID-19. However, few important questions regarding SARS-CoV-2 vaccine development are explored in this review.

Keywords: COVID-19; Vaccine; Vaccine backfires; Vaccine safety.

PubMed Disclaimer

Conflict of interest statement

CONFLICT OF INTEREST

The authors declare no conflict of interest.

Figures

Fig. 1
Fig. 1
State of the vaccine race for COVID-19.
Fig. 2
Fig. 2
COVID-19 and the vaccine. (A) A simple representation of the COVID-19 infection mechanism in the body. (B) Basic principles of vaccines in generalized form.
See this image and copyright information in PMC

References

    1. Adams E. R., Ainsworth M., Anand R., Andersson M. I., Auckland K., Baillie J. K., Barnes E., Beer S., Bell J. I., Berry T. Antibody testing for COVID-19: a report from the national COVID scientific advisory panel. Wellcome Open Res. 2020;5:139. doi: 10.12688/wellcomeopenres.15927.1. - DOI - PMC - PubMed
    1. Andersen K. G., Rambaut A., Lipkin W. I., Holmes E. C., Garry R. F. The proximal origin of SARS-CoV-2. Nat. Med. 2020;26:450–452. doi: 10.1038/s41591-020-0820-9. - DOI - PMC - PubMed
    1. Andrews S. M., Rowland-Jones S. Recent advances in understanding HIV evolution. F1000Res. 2017;6:597. doi: 10.12688/f1000research.10876.1. - DOI - PMC - PubMed
    1. Ascherio A., Zhang S. M., Hernán M. A., Olek M. J., Coplan P. M., Brodovicz K., Walker A. M. Hepatitis B vaccination and the risk of multiple sclerosis. N. Engl. J. Med. 2001;344:327–332. doi: 10.1056/NEJM200102013440502. - DOI - PubMed
    1. Bernstein K. E., Khan Z., Giani J. F., Cao D. Y., Bernstein E. A., Shen X. Z. Angiotensin-converting enzyme in innate and adaptive immunity. Nat. Rev. Nephrol. 2018;14:325–336. doi: 10.1038/nrneph.2018.15. - DOI - PMC - PubMed

LinkOut - more resources